5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
MULTICENTERS. Uncontrolled and open phase II study. Evaluation of the effectiveness of a
treatment associating 5 Azacytidine,Valproic acid ,Retinoic Acid at subjects-reached of
syndromes myelodysplasia and acute MYELOID leukaemia Hematological response at 6 months
Uncontrolled prospective cohort.